I’m hoping number 2. But KCSVEN could easily be right as well and they didn’t want to announce a date because of scheduling constraints with ADCOM members.
When’s the last time you heard the FDA say “earliest time we can schedule.”
If ADCOM members won’t come Nov 14 (and honestly it’s tight, I don’t blame them if they don’t), then they will extend the ADCOM date again, and here we are back at Jan 2020.
The biggest mystery is why NOW and not schedule the adcom months earlier?
If it really is JT wanting a broader label than the original SNDA asked for, he completely F’d up. Should have filed 2 separate SNDA’s.
I’m 50/50 on number 1 or 2. But if it is number 1, I don’t think Nov 14 holds.